NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 28 04:00PM ET
1.41
Dollar change
+0.01
Percentage change
0.71
%
Index- P/E- EPS (ttm)-0.54 Insider Own2.08% Shs Outstand90.85M Perf Week9.30%
Market Cap133.31M Forward P/E- EPS next Y-0.47 Insider Trans0.00% Shs Float88.96M Perf Month21.55%
Income-30.88M PEG- EPS next Q-0.10 Inst Own6.84% Short Float8.74% Perf Quarter0.00%
Sales0.00M P/S- EPS this Y15.00% Inst Trans14.31% Short Ratio4.89 Perf Half Y25.89%
Book/sh0.13 P/B11.02 EPS next Y-9.41% ROA-237.23% Short Interest7.77M Perf Year-8.44%
Cash/sh0.15 P/C9.53 EPS next 5Y42.51% ROE-4147.88% 52W Range0.77 - 1.84 Perf YTD35.58%
Dividend Est.- P/FCF- EPS past 5Y45.94% ROI-311.24% 52W High-23.37% Beta2.34
Dividend TTM- Quick Ratio1.72 Sales past 5Y22.63% Gross Margin- 52W Low82.64% ATR (14)0.09
Dividend Ex-DateMar 24, 2011 Current Ratio1.72 EPS Y/Y TTM60.51% Oper. Margin- RSI (14)72.67 Volatility6.13% 7.34%
Employees15 Debt/Eq0.11 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.83
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q64.03% Payout- Rel Volume1.37 Prev Close1.40
Sales Surprise- EPS Surprise43.77% Sales Q/Q- EarningsMar 20 AMC Avg Volume1.59M Price1.41
SMA2017.99% SMA5018.29% SMA20018.92% Trades Volume2,751,971 Change0.71%
Date Action Analyst Rating Change Price Target Change
Jul-21-21Initiated Cantor Fitzgerald Overweight $18
Nov-01-18Initiated Oppenheimer Outperform
Apr-02-18Initiated H.C. Wainwright Buy $11
Mar-19-18Upgrade Maxim Group Hold → Buy $13
Apr-28-25 08:45AM
Apr-23-25 10:23AM
Apr-08-25 08:45AM
Apr-05-25 12:37PM
Mar-31-25 03:03PM
04:05PM Loading…
Mar-20-25 04:05PM
Feb-27-25 10:10AM
Feb-21-25 07:29AM
Feb-20-25 08:45AM
Jan-28-25 03:11PM
Jan-23-25 08:10AM
Jan-08-25 08:20AM
Jan-02-25 08:00AM
Dec-10-24 08:30AM
Dec-09-24 08:45AM
05:37AM Loading…
Nov-28-24 05:37AM
Nov-27-24 08:45AM
Nov-13-24 04:15PM
Nov-05-24 09:55AM
Oct-15-24 08:45AM
Oct-10-24 04:05PM
Sep-18-24 03:09PM
Aug-13-24 04:10PM
Aug-06-24 08:45AM
Jul-31-24 08:30AM
Jul-16-24 09:05AM
Jul-08-24 08:45AM
Jun-24-24 09:05AM
Jun-17-24 09:45AM
09:05AM
08:40AM Loading…
Jun-10-24 08:40AM
May-14-24 10:54PM
04:05PM
May-01-24 08:35AM
Apr-29-24 08:45AM
Mar-28-24 10:54PM
04:05PM
07:00AM
Mar-26-24 07:35AM
Mar-19-24 04:05PM
08:47AM
Mar-15-24 09:00AM
Mar-08-24 08:00AM
Mar-01-24 08:30AM
Feb-29-24 08:00AM
Feb-06-24 08:30AM
Jan-25-24 08:45AM
Jan-11-24 06:00AM
Jan-10-24 11:30AM
Jan-09-24 08:30AM
Jan-04-24 09:01AM
08:41AM
Jan-03-24 08:05PM
07:30AM
Dec-27-23 08:55AM
Dec-21-23 08:15AM
Dec-14-23 08:30AM
Dec-13-23 08:30AM
Dec-04-23 08:47AM
Nov-29-23 08:45AM
Nov-13-23 08:50AM
Nov-09-23 04:04PM
Nov-06-23 08:57AM
Oct-31-23 08:05AM
Oct-30-23 09:03AM
Oct-17-23 08:45AM
Oct-16-23 08:45AM
Oct-12-23 04:05PM
Oct-11-23 08:30AM
Oct-10-23 04:15PM
07:00AM
Sep-21-23 08:30AM
Sep-18-23 04:19PM
Aug-22-23 08:30AM
Aug-10-23 04:08PM
Jul-15-23 09:25AM
Jun-28-23 04:00PM
08:30AM
Jun-22-23 08:45AM
Jun-15-23 04:05PM
Jun-13-23 08:30AM
May-25-23 05:05PM
May-16-23 08:30AM
May-11-23 04:12PM
May-04-23 08:30AM
Apr-26-23 04:01PM
Apr-20-23 08:30AM
Apr-18-23 08:30AM
Mar-16-23 04:11PM
Mar-07-23 08:30AM
Feb-24-23 08:42AM
08:30AM
07:29AM
Feb-23-23 04:01PM
Feb-05-23 07:57AM
Jan-19-23 08:30AM
Jan-05-23 08:30AM
Dec-13-22 02:49PM
08:30AM
Dec-08-22 08:30AM
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.